Fundraising Fox
Vivus
2 known investors
Find your way into Vivus
Sign up to see every warm intro you have to Vivus
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vivus team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
VIVUS is a pharmaceutical company developing and commercializing therapies for patients with serious medical conditions and life-limiting diseases. The company advances innovative treatments through clinical development and commercialization expertise.
Founders & leadership
ST
Santosh T. VarghesePresident VIVUS Global Pharmaceutical Development & Chief Medical OfficerSantosh T. Varghese has over 25 years of pharmaceutical industry experience spanning clinical development, medical affairs, and regulatory strategy across cardiovascular, endocrinology, immunotherapy, CNS, and multiple other therapeutic areas. He holds medical training in general medicine and has led cross-functional teams in clinical development, medical affairs, pharmacovigilance, and regulatory organizations.
Investors · 2
Frequently asked questions
- What does Vivus do?
- VIVUS is a pharmaceutical company developing and commercializing therapies for patients with serious medical conditions and life-limiting diseases. The company advances innovative treatments through clinical development and commercialization expertise.
- Who are Vivus's investors?
- Vivus's investors include Aisling Capital, Frazier Life Sciences.